Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18929163 | 0.90 | PLA2G4A (0.33) | PLA2G4AABCB1L3MBTL1 | |
| SCHEMBL23736678 | 0.89 | ABCB1 (0.43) | ABCB1 | |
| SCHEMBL18928757 | 0.89 | ABCB1 (0.37) | ABCB1 | |
| SCHEMBL20159728 | 0.87 | PLA2G4A (0.31) | PLA2G4A | |
| SCHEMBL24872378 | 0.87 | PLA2G4A (0.31) | PLA2G4A | |
| SCHEMBL20393440 | 0.87 | PLA2G4A (0.38) | PLA2G4AABCB1L3MBTL1 | |
| SCHEMBL22863836 | 0.87 | ESR2 (0.31) | L3MBTL1 | |
| SCHEMBL23894110 | 0.87 | ESR2 (0.31) | L3MBTL1 | |
| SCHEMBL19293115 | 0.86 | PLA2G4A (0.32) | PLA2G4AABCB1 | |
| SCHEMBL18928763 | 0.85 | PLA2G4A (0.41) | PLA2G4AABCB1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3210627-A1 | CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS | Hangzhou Dac Biotech Co., Ltd (CN) | 2017-08-30 | — | — | EP | disclosed |
| US-20170157262-A1 | CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157262-A1 | CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS | CD4, CD2, CD47 | PLA2G4A 2320/4885ABCB1 973/4885L3MBTL1 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.